New York, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Esbriet (pirfenidone) - Drug Insight and Market Forecast - 2030 ...

Idiopathic pulmonary fibrosis represents a high need specialty market, with global IPF drug sales of roughly USD 3 billion ...

Review the side-effects of Pirfenidone as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

Pulmonary Fibrosis Xray When treated with pirfenidone, patients with idiopathic pulmonary fibrosis experienced significant improvements in 6-minute walking distance and University of California San ...

Patients with heart failure with preserved ejection fractionwho took the antifibrotic drug pirfenidone saw a significant reduction in a marker of heart muscles carring compared with patients who ...

According to the latest data from TRANSLATE-HF platform, a collaboration among the American Heart Association (AHA), AstraZeneca, and the Duke Clinical Research Institute, patients with heart failure ...

A symposium on idiopathic pulmonary fibrosis (IPF), which was presented on behalf of InterMune, Inc, highlighted clinical data supporting the use of pirfenidone in patients with IPF. Leading the panel ...

When treated with pirfenidone, patients with idiopathic pulmonary fibrosis experienced significant improvements in 6-minute walking distance and University of California San Diego Shortness of Breath ...

Details concerning the Pirfenidone combination medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, liquids, and ...

New York, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Esbriet (pirfenidone) - Drug Insight and Market Forecast - 2030 ...